Intuitive Surgical (ISRG)

Resolving a major litigation settlement while expanding into cost-sensitive outpatient centers positions the company for sustained procedure growth.

Revenue hit $3.05 billion as procedure volumes surged and system placements accelerated.

Medical technology company Intuitive Surgical (NASDAQ:ISRG) beat Wall Street’s revenue expectations in Q3 2026, with sales up 21.7% year on year to $3.05 bil...

Intuitive Surgical (NASDAQ:ISRG) reported third-quarter 2026 revenue growth of 22% to just over $3 billion as procedure growth, system placements and adoption of newer platforms supported results. The company said 84% of quarterly revenue was recurring revenue, while non-GAAP earnings per share rose

Medical technology company Intuitive Surgical (NASDAQ:ISRG) beat Wall Street’s revenue expectations in Q3 2026, with sales up 21.7% year on year to $3.05 bil...

Robotic surgery is growing, procedures are climbing, and da Vinci 5 is rolling out. Is Intuitive Surgical's premium valuation worth paying?

Medical technology company Intuitive Surgical (NASDAQ:ISRG) will be announcing earnings results this Tuesday after market hours. Here’s what investors should...

I'm a shareholder, myself, with no plans to sell.

Johnson & Johnson posted Q3 revenue growth of 5.9% to $25.4 billion, raised guidance, and gained analyst support as its OTTAVA surgical system and talc settlement shape its long-term outlook.

Abbott trades at a 18x forward P/E with $7.4B in free cash flow, while Intuitive Surgical commands a 39x multiple backed by zero debt and 20% revenue growth.

Two healthcare stocks that are leading their niches, and two that investors aren't giving enough credit to in the same niches.

Physical AI is moving from software into machines, but the winners may come from very different layers. See which business models have the strongest growth, monetization, and durability.

Don't underestimate this healthcare giant.

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...

These companies haven't said their last words.

Intuitive Surgical is beating estimates and raising margins while its installed base keeps expanding. Abbott is executing steadily across a diversified portfolio but growing at a more measured pace.

Analysts think this beaten-down healthcare stock will rebound.

This is not an exhaustive list.

Wall Street thinks that this robotic surgical systems leader's sell-off is overdone.